Huntsman Cancer Institute leading cancer clinical trials across Utah and partner sites

Huntsman Cancer Institute/ University of Utah Network Lead Academic Participating Site Application

NIH-funded research Utah State Higher Education System--University of Utah · NIH-11291152

This effort expands access to cancer clinical trials so people with many types of cancer in Utah and nearby regions can join new treatment and imaging studies.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah NIH-funded
Lab location1 site (Salt Lake City, United States)
Project IDNIH-11291152 on NIH RePORTER

What this research studies

Huntsman Cancer Institute at the University of Utah is acting as a lead site in the National Clinical Trials Network to open and run multi-center cancer treatment and imaging trials. As a Network Lead Academic Participating Site, HCI coordinates trial activation, enrollment, and collaboration with national cooperative groups under experienced medical and radiation oncology leaders. The team runs dozens of open NCTN trials at a time, including studies for rare cancers and short-course radiation approaches, and averaged about 100 enrollments per year in the current grant cycle. If you participate, you would access nationally coordinated trials through HCI and could be offered new therapies, imaging studies, or opportunities to contribute samples for research.

Who could benefit from this research

Good fit: People with cancer who are eligible for National Clinical Trials Network protocols and who can attend Huntsman Cancer Institute or affiliated clinics are the ideal candidates.

Not a fit: Patients who are not eligible for any open NCTN trial or who cannot travel to the Salt Lake City area are unlikely to receive direct benefit from this site-focused effort.

Why it matters

Potential benefit: If successful, this work could increase local access to cutting-edge cancer treatments and clinical trials for people in the region.

How similar studies have performed: HCI has served as a network lead site since 2014 and has a track record of enrolling patients to NCTN trials, so this is an established, proven model rather than an untested approach.

Where this research is happening

Salt Lake City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer CenterCancer TreatmentCancers
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.